Predicting Factors for Mortality in Congenital Heart Disease Patients After Shunt Procedure in Developing Country.

Completed

• Conditions: Cyanotic Congenital Heart Disease

• Registration Number: NCT05800691
• Lead Sponsor: Universitas Sumatera Utara

Brief Summary

Blalock Taussig (BT) is a palliative procedure that preserves blood circulation to the lungs and alleviates cyanosis in patients with congenital heart diseases and reduced pulmonary blood flow. BT shunt remains a routinely performed procedure in developing countries before definitive surgery. However, evidence on predictors factors of mortality after this procedure is still scarce in Indonesia.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-11-01
• Primary Completion: 2021-01-31
• Study Completion: 2021-01-31
• Study First Submitted: 2023-03-12
• Study First Submitted QC: 2023-03-23
• Study First Posted: 2023-04-05
• Status Verified: 2023-08
• Last Update Submitted: 2023-08-04
• Last Update Posted: 2023-08-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 197

Inclusion Criteria

• All CHD pediatric patients with a previous history of BT shunt procedure.

Read More

Exclusion Criteria

• Pediatric patients with incomplete medical records

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
In-Hospital Mortality	November 2020 - January 2021	Death occured to patients during in hospital stay

Trial Locations

Locations (1)

Universitas Sumatera Utara; 🇮🇩 Medan, North Sumatera, Indonesia